• MD with 30 years’ experience in pharmaceuticals. • Senior roles at Pfizer, including development of Aricept™, the current leading AD treatment.
• Biotechnology entrepreneur and executive, with financial market capital raising experience, having raised over $100 M cash equity. • Non-Executive Director of Oncosil Medical (ASX:OSL).
Dr. Jason Loveridge
• Over 20 years’ experience in developing clinical stage biotechnology companies. • Director JAFCO Nomura London. • Participated in over 29 biotech investments in the EU, US and Israel. • Non-Executive Director of Resonance Health...
Dr. Anton Uvarov
• Healthcare and biotech equities analyst, formerly Citibank NY. • Non-Executive Director Imugene (ASX: IMU).
• 23 years of company secretarial experience • Managing director of Platinum Corporate Secretariat, and Non-Executive Director of Cynata.
Vice President of Clinical Research
• Extensive drug development experience over 20 years. • Responsible clinical development and regulatory strategy.